<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03407313</url>
  </required_header>
  <id_info>
    <org_study_id>CLP-0002</org_study_id>
    <nct_id>NCT03407313</nct_id>
  </id_info>
  <brief_title>CONFORM: Rotational Fractional Resection for Submental Contouring</brief_title>
  <official_title>The CONFORM Study: A Multi-center Study to Evaluate the Safety and Efficacy of Rotational Fractional Resection on Submental Contouring</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Recros Medica, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Recros Medica, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the safety and efficacy of rotational fractional resection (RFR) to&#xD;
      improve neck contouring. RFR is used to remove loose skin and fat.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, multi-center, single-arm (non-randomized), interventional cohort,&#xD;
      non-significant risk (NSR) study designed to investigate the efficacy and safety of&#xD;
      Rotational Fractional Resection (skin resection and focal lipectomy) in patients with mild to&#xD;
      moderate submental fat and mild to moderate submental skin laxity. The total duration of&#xD;
      study participation for each subject is approximately up to 7 months for each subject from&#xD;
      the screening visit to the exit visit. The follow-up period will be approximately 6 months&#xD;
      after the procedure. Eligible subjects will complete a total of 8 study visits: screening,&#xD;
      procedure, and follow-up visits at 1, 7, 14, 30, 90 and 180 days post-procedure.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 8, 2018</start_date>
  <completion_date type="Actual">April 23, 2019</completion_date>
  <primary_completion_date type="Actual">December 28, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With a Reduction of Submental Skin Area ≥ 20 mm^2</measure>
    <time_frame>Baseline and 90 days post treatment</time_frame>
    <description>This endpoint is the difference in the measurement of submental skin area (mm^2) between Baseline and 90 days. A reduction of ≥ 20 mm^2 denotes improvement.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Who Were Satisfied With the Appearance of Their Neck and Jawline</measure>
    <time_frame>90 days after treatment</time_frame>
    <description>Subjects rated their satisfaction of the appearance of their neck and jawline on a Subject Satisfaction Questionnaire. Results reflect subjects who were satisfied (&quot;somewhat satisfied&quot;, &quot;satisfied&quot;, or &quot;very satisfied&quot;).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Post-treatment Images Correctly Identified</measure>
    <time_frame>Pre-treatment and 90 days after treatment</time_frame>
    <description>Correct identification of post-treatment images by three blinded independent reviewers in more than 50% of subjects</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">68</enrollment>
  <condition>Skin Laxity</condition>
  <condition>Lipodystrophy</condition>
  <arm_group>
    <arm_group_label>Rotational fractional resection (1.5mm diameter device)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single treatment of skin resection and focal lipectomy (removal of loose skin and fat)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Rotational fractional resection (1.5mm diameter device)</intervention_name>
    <description>Single treatment of skin resection and focal lipectomy (removal of loose skin and fat)</description>
    <arm_group_label>Rotational fractional resection (1.5mm diameter device)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy male or female, at least 30 years old&#xD;
&#xD;
          -  Moderate submental (neck) fat&#xD;
&#xD;
          -  Mild to moderate submental (neck) skin laxity (loose skin)&#xD;
&#xD;
          -  Willing and able to provide informed consent&#xD;
&#xD;
          -  Willing and able to comply with all protocol requirements&#xD;
&#xD;
          -  Willing to limit direct sun exposure and use sunscreen for duration of the study&#xD;
&#xD;
          -  Agree to maintain weight for duration of the study&#xD;
&#xD;
          -  Willing to have photographs taken that could identify the participant&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Previous intervention to treat submental fat or skin laxity&#xD;
&#xD;
          -  Use of aspirin, ibuprofen, naproxen, or Vitamin E within 14 days of the procedure&#xD;
&#xD;
          -  Sensitivity to local anesthesia&#xD;
&#xD;
          -  Severe acne, cystic acne or acne scars on neck&#xD;
&#xD;
          -  Trauma of chin or neck area&#xD;
&#xD;
          -  Skin infection or rash on neck&#xD;
&#xD;
          -  Psoriasis, eczema, rosacea, or vitiligo&#xD;
&#xD;
          -  History of scarring&#xD;
&#xD;
          -  History or current symptoms of dysphagia&#xD;
&#xD;
          -  Chronic or persistent coughing&#xD;
&#xD;
          -  Body mass index (BMI) &gt; 30&#xD;
&#xD;
          -  Clinically significant bleeding disorder&#xD;
&#xD;
          -  Anemia, kidney disease, or liver disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Edward W Knowlton, MD</last_name>
    <role>Study Director</role>
    <affiliation>Recros Medica, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Aesthetx</name>
      <address>
        <city>Campbell</city>
        <state>California</state>
        <zip>95008</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Steve Yoelin, MD Medical Associates, Inc.</name>
      <address>
        <city>Newport Beach</city>
        <state>California</state>
        <zip>92663</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Roseville Facial Plastic Surgery</name>
      <address>
        <city>Roseville</city>
        <state>California</state>
        <zip>95661</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Miami Dermatology &amp; Laser Institute</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33173</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>DeNova Research</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sundaram Dermatology, Cosmetic &amp; Laser Surgery Center</name>
      <address>
        <city>Fairfax</city>
        <state>Virginia</state>
        <zip>22031</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 16, 2018</study_first_submitted>
  <study_first_submitted_qc>January 16, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 23, 2018</study_first_posted>
  <results_first_submitted>September 22, 2020</results_first_submitted>
  <results_first_submitted_qc>January 15, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">February 3, 2021</results_first_posted>
  <last_update_submitted>January 15, 2021</last_update_submitted>
  <last_update_submitted_qc>January 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Submental fullness</keyword>
  <keyword>Submental fat</keyword>
  <keyword>Loose skin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lipodystrophy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>October 18, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/13/NCT03407313/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Rotational Fractional Resection (1.5mm Diameter Device)</title>
          <description>Single treatment of skin resection and focal lipectomy (removal of loose skin and fat) in submentum</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="68"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="66"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Rotational Fractional Resection (1.5mm Diameter Device)</title>
          <description>Single treatment of skin resection and focal lipectomy (removal of loose skin and fat) in submentum</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="68"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56.9" spread="6.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="59"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="58"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="67"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index (BMI)</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24.7" spread="3.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Fitzpatrick Skin Type</title>
          <description>Fitzpatrick Skin Type (Grades I through IV) is a numerical classification schema for human skin color</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Type I - Ivory white (pale white); extremely fair skin</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Type II - White or fair skin</title>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Type III - Medium white skin</title>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Type IV - Beige or lightly tanned or olive skin</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Type V - Moderately brown or tanned brown skin</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Type VI - Dark brown or black skin</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With a Reduction of Submental Skin Area ≥ 20 mm^2</title>
        <description>This endpoint is the difference in the measurement of submental skin area (mm^2) between Baseline and 90 days. A reduction of ≥ 20 mm^2 denotes improvement.</description>
        <time_frame>Baseline and 90 days post treatment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Rotational Fractional Resection (1.5mm Diameter Device)</title>
            <description>Single treatment of skin resection and focal lipectomy (removal of loose skin and fat) in submentum</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With a Reduction of Submental Skin Area ≥ 20 mm^2</title>
          <description>This endpoint is the difference in the measurement of submental skin area (mm^2) between Baseline and 90 days. A reduction of ≥ 20 mm^2 denotes improvement.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="68"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Who Were Satisfied With the Appearance of Their Neck and Jawline</title>
        <description>Subjects rated their satisfaction of the appearance of their neck and jawline on a Subject Satisfaction Questionnaire. Results reflect subjects who were satisfied (&quot;somewhat satisfied&quot;, &quot;satisfied&quot;, or &quot;very satisfied&quot;).</description>
        <time_frame>90 days after treatment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Rotational Fractional Resection (1.5mm Diameter Device)</title>
            <description>Single treatment of skin resection and focal lipectomy (removal of loose skin and fat) in submentum</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Were Satisfied With the Appearance of Their Neck and Jawline</title>
          <description>Subjects rated their satisfaction of the appearance of their neck and jawline on a Subject Satisfaction Questionnaire. Results reflect subjects who were satisfied (&quot;somewhat satisfied&quot;, &quot;satisfied&quot;, or &quot;very satisfied&quot;).</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="68"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Post-treatment Images Correctly Identified</title>
        <description>Correct identification of post-treatment images by three blinded independent reviewers in more than 50% of subjects</description>
        <time_frame>Pre-treatment and 90 days after treatment</time_frame>
        <population>68 subjects were assessed by three blinded reviewers</population>
        <group_list>
          <group group_id="O1">
            <title>Rotational Fractional Resection (1.5mm Diameter Device)</title>
            <description>Single treatment of skin resection and focal lipectomy (removal of loose skin and fat) in submentum</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Post-treatment Images Correctly Identified</title>
          <description>Correct identification of post-treatment images by three blinded independent reviewers in more than 50% of subjects</description>
          <population>68 subjects were assessed by three blinded reviewers</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="68"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Blinded Reviewer 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Blinded Reviewer 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Blinded Reviewer 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>180 days</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Rotational Fractional Resection (1.5mm Diameter Device)</title>
          <description>Single treatment of skin resection and focal lipectomy (removal of loose skin and fat) in submentum</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="68"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="68"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="45" subjects_at_risk="68"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="68"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Administration site erythema</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="68"/>
              </event>
              <event>
                <sub_title>Administration site bruising</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="68"/>
              </event>
              <event>
                <sub_title>Contact Dermatitis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="68"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="68"/>
              </event>
              <event>
                <sub_title>Abnormal Skin Texture</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="68"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Skin Mass</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="68"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>This study evaluated 1.5mm diameter skin resections, our first-generation prototype, in the submentum area.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Head of Clinical Development</name_or_title>
      <organization>Recros Medica</organization>
      <phone>925-223-8581</phone>
      <email>clinical@recrosmedica.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

